FINNENCE ▪ THE WIRE FILE
THE WIRE · № 57019
News■ Unclear/unknown
Astrocyte Pharmaceuticals Secures $9.5 Million Series B to Advance Phase 2 Clinical Development of Breakthrough TBI and Concussion Therapy AST-004

KINDNews
DIRECTION■ Unclear/unknown
SOURCES1
ENTITIES1
STORY SIZESTANDALONE
FIRST SEEN2026-09-30 10:00 UTC
LAST UPDATE2026-09-30 10:00 UTC
STATEactive
01 THE MACHINE READ
WHY IT MATTERS.
A $9.5M Series B for a private biotech is small and pre-revenue, with topline data still pending.
Early-stage private raise, no public read
CATALYST TO WATCH
Winter topline concussion trial results
MAIN RISK
Phase 2 failure would erase the thesis
FULL DISPATCH
Enrollment Complete in STARFAST Sports-Related Concussion Trial; Topline Results Expected This Winter GROTON, Conn., Sept. 30, 2026 /PRNewswire/ -- Astrocyte Pharmaceuticals Inc., a pioneering clinical-stage biotechnology company developing first-in-class cerebroprotective therapies for...
02 THE STORY SO FAR
THE RECORD, IN ORDER.
STANDALONE ITEM — NOT YET FOLDED INTO A DEVELOPING STORY.
03 WHO'S INVOLVED
ENTITIES ON FILE.
AFFECTEDHealthcare
04 RECEIPTS
THE SOURCE RECORD.
1 SOURCES CONFIRMED05 PROPAGATION
WHAT THIS TOUCHES.
→CORRELATIONshares Healthcare
The Cigna Group Hosts 2026 Investor Day; Introduces "Lead to One" to Drive Durable Growth Through Complex Care Leadership and Differentiated Capabilities2026-09-30 11:00 UTC
The Cigna Group Hosts 2026 Investor Day; Introduces "Lead to One" to Drive Durable Growth Through Complex Care Leadership and Differentiated Capabilities2026-09-30 11:00 UTC
→CORRELATIONshares Healthcare
CytoSorbents Announces New Data Presentations at Upcoming International Conferences in Cardiac Surgery and Critical Care2026-09-30 11:00 UTC
CytoSorbents Announces New Data Presentations at Upcoming International Conferences in Cardiac Surgery and Critical Care2026-09-30 11:00 UTC
→CORRELATIONshares Healthcare
EASD 2026 | Ecnoglutide Demonstrates Favorable Safety Profile in Adolescents with Obesity2026-09-30 11:00 UTC
EASD 2026 | Ecnoglutide Demonstrates Favorable Safety Profile in Adolescents with Obesity2026-09-30 11:00 UTC
←CORRELATIONshares Healthcare
Wake County leaders tout growth, defend WakeMed-Atrium merger2026-09-29 23:13 UTC
Wake County leaders tout growth, defend WakeMed-Atrium merger2026-09-29 23:13 UTC
←CORRELATIONshares Healthcare
Roche launches newborn screening test for three severe genetic conditions2026-09-30 05:00 UTC
Roche launches newborn screening test for three severe genetic conditions2026-09-30 05:00 UTC
←CORRELATIONshares Healthcare
AbbVie Showcases Leadership in Dermatology Research With New Clinical and Real-World Evidence Across Immune-Mediated Skin Diseases at 2026 EADV Congress2026-09-30 05:00 UTC
AbbVie Showcases Leadership in Dermatology Research With New Clinical and Real-World Evidence Across Immune-Mediated Skin Diseases at 2026 EADV Congress2026-09-30 05:00 UTC
KEEP READING THE MACHINE
Summaries are generated and may contain errors — every claim links its sources.